About
ResoTher Pharma is a clinical-stage biotechnology company developing peptide-based drugs as resolution therapy targeting neutrophil-driven inflammation to treat cardiovascular diseases such as myocardial infarction.
Explore ResoTher Pharma's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.